Maryland Oncology Hematology, P.A.

Frederick, Maryland 21702

0 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, HER2-positive Breast Cancer, Metastatic Breast Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• Palbociclib in Real World Practice — Completed